Apta Biosciences has created a revolutionary, patented method for producing artificial antibodies, which are essential components of medical diagnosis and treatment. As a spin-off from Fujitsu, our cutting-edge technology offers a game-changing alternative to traditional antibody production methods.
Headquarters:
Singapore
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2013 (13 years)
Address:
21 ALBEMARLE STREET; LONDON, ENGLAND W1S 4, GB
LOW
spending power